TCIM
MYOK

TIAA CREF Investment Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

TIAA CREF Investment Management’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$5.41M Sell
103,990
-1,805
-2% -$83.2K ﹤0.01% 1397
2018
Q4 		$5.17M Buy
105,795
+950
+0.9% +$52.3K ﹤0.01% 1355
2018
Q3 		$6.84M Buy
104,845
+29,722
+40% +$1.75M ﹤0.01% 1364
2018
Q2 		$3.73M Sell
75,123
-100,259
-57% -$4.85M ﹤0.01% 1811
2018
Q1 		$8.56M Buy
175,382
+2,313
+1% +$120K 0.01% 1208
2017
Q4 		$7.29M Buy
173,069
+21,338
+14% +$822K ﹤0.01% 1367
2017
Q3 		$6.5M Buy
151,731
+49,448
+48% +$1.58M ﹤0.01% 1459
2017
Q2 		$1.34M Buy
102,283
+67,827
+197% +$894K ﹤0.01% 2403
2017
Q1 		$453K Sell
34,456
-6,900
-17% -$88.4K ﹤0.01% 2824
2016
Q4 		$536K Sell
41,356
-3,625
-8% -$55.8K ﹤0.01% 2815
2016
Q3 		$735 Sell
44,981
-2,204
-5% -$39.8K ﹤0.01% 2698
2016
Q2 		$585K Buy
47,185
+39,412
+507% +$493K ﹤0.01% 2794
2016
Q1 		$83K Buy
+7,773
New +$70.7K ﹤0.01% 3040

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return